# Efficacy of YKP3089 in Patients With Photosensitive Epilepsy

> **NCT00616148** · PHASE2 · COMPLETED · sponsor: **SK Life Science, Inc.** · enrollment: 11 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** YKP3089
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00616148
- **Lead sponsor:** SK Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-01
- **Final completion:** 2010-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00616148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00616148, "Efficacy of YKP3089 in Patients With Photosensitive Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00616148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*